Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 20
Encontrada(s) 1 página(s)

Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

Metabolic disturbances in urinary and plasma samples from seven different systemic autoimmune diseases detected by HPLC-ESI-QTOF-MS

  • Fernández Ochoa, Álvaro
  • Brunius, Carl
  • Borras Linares, María Isabel
  • Quirantes Piné, Rosa
  • Cádiz Gurrea, María de la Luz|||0000-0002-2613-4889
  • Alarcón Riquelme, Marta Eugenia
  • Segura Carretero, Antonio
Systemic autoimmune diseases (SADs) are characterized by dysfunctioning of the immune system, which causes damage in several tissues and organs. Among these pathologies are systemic lupus erythematosus (SLE), systemic sclerosis or scleroderma, Sjögren’s syndrome, rheumatoid arthritis, primary antiphospholipid syndrome (PAPS), mixed connective tissue disease (MCTD), and undifferentiated connective tissue disease (UCTD). Early diagnosis is difficult due to similarity in symptoms, signs, and clinical test results. Hence, our aim was to search for differentiating metabolites of these diseases in plasma and urine samples. We performed metabolomic profiling by liquid chromatography–mass spectrometry (LC–MS) of samples from 228 SADs patients and 55 healthy volunteers. Multivariate PLS models were applied to investigate classification accuracies and identify metabolites differentiating SADs and healthy controls. Furthermore, we specifically investigated UCTD against the other SADs. PLS models were able to classify most SADs vs healthy controls (area under the roc curve (AUC) > 0.7), with the exception of MCTD and PAPS. Differentiating metabolites consisted predominantly of unsaturated fatty acids, acylglycines, acylcarnitines, and amino acids. In accordance with the difficulties in defining UCTD, the UCTD metabolome did not differentiate well from the other SADs. However, most UCTD cases were classified as SLE, suggesting that metabolomics may provide a tool to reassess UCTD diagnosis into other conditions for more well-informed therapeutic strategies., This study has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement nº. 115565, resources of which are composed of the financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and the EFPIA companies’ in kind contribution. The author AFO gratefully acknowledges the Spanish Ministry of Education, Culture and Sports for the received grant FPU14/03992.
Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

Discovering new metabolite alterations in primary Sjögren’s Syndrome in urinary and plasma samples using an HPLC-ESI-QTOF-MS methodology

  • Fernández Ochoa, Álvaro
  • Borras Linares, María Isabel
  • Quirantes-Piné, Rosa
  • PRECISESADS Clinical Consortium
  • Alarcón Riquelme, Marta Eugenia
  • Beretta, Lorenzo
  • Segura Carretero, Antonio
The work described has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement No. 115565, the resources for which are composed of a financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) companies’ in-kind contribution. We thank all the members of PRECISESADS Clinical Consortium (Table 6S) for their effort in the sample recruitment, distribution and assessment of the samples used in this study. The author AFO gratefully acknowledges the Spanish Ministry of Education, Culture and Sports for the FPU grant (FPU14/03992)., Sjögren’s Syndrome (SjS) is a complex autoimmune disease characterized by the affection of the exocrine glands and the involvement of multiple organs. Although a greater number of biomarker studies have been carried out in recent years, the origin and pathogenesis are not yet well known and therefore there is a need to continue studying this pathology. This work aims to find metabolic changes in biological samples (plasma and urine), which could help identify the metabolic pathways affected by the SjS pathogenesis. The samples collected from SjS patients and healthy volunteers were analyzed by a fingerprinting metabolomic approach based on HPLC-ESI-QTOF-MS methodology. After feature pre-selection by univariate statistical tests, an integrated PLS-DA model using data from urine and plasma was constructed obtaining a good classification between cases and controls (AUROC = 0.839 ± 0.021). 31 and 38 metabolites in plasma and urine, respectively, showed significant differences between healthy volunteers and SjS patients and were proposed for their identification. From them, 12 plasma and 24 urinary metabolites could be annotated. In general, the main metabolic pathways altered in SjS patients were related to the metabolism of phospholipids, fatty acids, and amino acids, specially tryptophan, proline and phenylalanine., European Union’s Seventh Framework Programme (FP7/2007-2013) 115565, European Federation of Pharmaceutical Industries and Associations (EFPIA), Spanish Ministry of Education, Culture and Sports (FPU14/03992)
Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

A comprehensive database for integrated analysis of omics data in autoimmune diseases

  • Martorell Marugán, Jordi
  • López Domínguez, Raúl|||0000-0003-3115-2894
  • García Moreno, Adrián
  • Toro Domínguez, Daniel
  • Villatoro García, Juan Antonio
  • Barturen, Guillermo
  • Alarcón Riquelme, Marta Eugenia
  • Carmona Sáez, Pedro|||0000-0002-6173-7255
This work is partially funded by FEDER/Junta de Andalucia-Consejeria de Economia y Conocimiento (Grant CV20-36723), Consejeria de Salud (Grant PI-0173-2017) and by EU/EFPIA Innovative Medicines Initiative Joint Undertaking PRECISESADS (115565). JMM is partially funded by Ministerio de Economia, Industria y Competitividad. None of the funding bodies played any role in the design of the study and collection, analysis, and interpretation of data nor in writing the manuscript., Background: Autoimmune diseases are heterogeneous pathologies with difficult diagnosis and few therapeutic options. In the last decade, several omics studies have provided significant insights into the molecular mechanisms of these diseases. Nevertheless, data from different cohorts and pathologies are stored independently in public repositories and a unified resource is imperative to assist researchers in this field. Results: Here, we present Autoimmune Diseases Explorer (https:// adex. genyo. es), a database that integrates 82 curated transcriptomics and methylation studies covering 5609 samples for some of the most common autoimmune diseases. The database provides, in an easy-to-use environment, advanced data analysis and statistical methods for exploring omics datasets, including meta-analysis, differential expression or pathway analysis. Conclusions: This is the first omics database focused on autoimmune diseases. This resource incorporates homogeneously processed data to facilitate integrative analyses among studies., FEDER/Junta de Andalucia-Consejeria de Economia y Conocimiento CV20-36723, Consejeria de Salud PI-0173-2017, EU/EFPIA Innovative Medicines Initiative Joint Undertaking PRECISESADS 115565, Ministerio de Economia, Industria y Competitividad
Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

Urinary and plasma metabolite differences detected by HPLC-ESI-QTOF-MS in systemic sclerosis patients.

  • Fernández Ochoa, Álvaro
  • Quirantes-Piné, Rosa
  • Borras Linares, María Isabel
  • Gemperline, David
  • PRECISESADS Clinical Consortium
  • Alarcón Riquelme, Marta Eugenia
  • Beretta, Lorenzo
  • Segura Carretero, Antonio
The work described has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement No. 115565, the resources for which are composed of a financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) companies’ in-kind contribution. The author IBL gratefully acknowledges the Spanish Ministry of Economy and Competitiveness (MINECO) in association with the European Social Fund (FSE) for the contract PTQ-13-06429, the author AFO received support from the Spanish Ministry of Education, Culture and Sports (FPU grant 14/03992)., Systemic Sclerosis (SSc) is a chronic autoimmune disease whose origin and pathogenesis are not yet well known. Recent studies are allowing a better definition of the disease. However, few studies have been performed based on metabolomics. In this way, this study aims to find altered metabolites in SSc patients in order to improve their diagnosis, prognosis and treatment. For that, 59 SSc patients and 28 healthy volunteers participated in this study. Urine and plasma samples were analyzed by a fingerprinting metabolomic approach based on HPLC-ESI-QTOF-MS. We observed larger differences in urine than plasma metabolites. The main deregulated metabolic families in urine were acylcarnitines, acylglycines and metabolites derived from amino acids, specifically from proline, histidine and glutamine. These results indicate perturbations in fatty acid beta oxidation and amino acid pathways in scleroderma patients. On the other hand, the main plasma biomarker candidate was 2-arachidonoylglycerol, which is involved in the endocannabinoid system with potential implications in the induction and propagation of systemic sclerosis and autoimmunity., European Union’s Seventh Framework Programme (FP7/2007-2013) 115565, European Federation of Pharmaceutical Industries and Associations (EFPIA), Spanish Ministry of Economy and Competitiveness (MINECO), European Social Fund (FSE) PTQ-13-06429, Spanish Ministry of Education, Culture and Sports (FPU grant 14/03992)
Repositori Obert UdL
Publication Capítulo o parte de un libro (BookPart)

I viceré conti di Miranda e la circolazione di reliquie nella Spagna tra Cinque e Seicento, Viceroy counts of Miranda and the circulation of relics in Spain between the sixteenth and seventeenth centuries

  • Viceconte, Milena
Il presente lavoro si propone di affrontare il fenomeno della circolazione di reliquie tra l’Italia e la Spagna durante prima età moderna, attraverso l’analisi delle raccolte dei VI conti di Miranda e delle loro donazioni alle fondazioni religiose spagnole. Come attestano varie fonti d’archivio, i conti María e Juan de Zúñiga y Avellaneda (costui viceré di Napoli tra il 1586 e il 1595) effettuarono durante il soggiorno a Napoli varie acquisizioni di reliquie e opere d’arte a soggetto sacro, che furono oggetto in momenti diversi di donazioni ai luoghi religiosi legati al patronato familiare, come la chiesa di Nuestra Señora de la Vid, che dal 1420 ospitava il pantheon dei Zúñiga y Avellaneda. Di particolare interesse è la donazione alle monache agostiniane del monastero di patronato reale dell'Encarnación di Madrid nel 1630 da parte della contessa di Miranda per disposizione testamentaria, in quanto portò al trasferimento di un corpus significativo di resti sacri, tra cui un’ampolla con il sangue del martire Pantaleone de Nicomedia. Attorno a tale reliquia, che una volta l’anno è oggetto del singolare fenomeno della liquefazione, si generò sin da subito una speciale venerazione, destinata a divenire un tratto distintivo della spiritualità di questo complesso monastico., The present paper aims to examine the phenomenon of the circulation of relics between Italy and Spain during the early modern period, through the analysis of the collections of the VI counts of Miranda and their donations to Spanish religious foundations. As documented by several archive records, the counts María and Juan de Zúñiga y Avellaneda (the latter viceroy of Naples between 1586 and 1595) made a number of acquisitions of relics and religious works of art during their stay in Naples, which were donated at different moments to the religious institutions linked to their family patronage, such as the church of Nuestra Señora de la Vid, which had housed the pantheon of the Zúñiga y Avellaneda family since 1420. The donation to the Augustinian nuns of the Royal Patronage Monastery of the Encarnación in Madrid in 1630, ordered by the Countess of Miranda by testamentary disposition, was especially interesting, as it allowed the transfer of a significant corpus of sacred remains, including an ampoule with the blood of the martyr Pantaleon of Nicomedia. Around this relic, which once a year is subject to the singular phenomenon of liquefaction, a special veneration was immediately generated, which was soon become a distinctive feature of the spirituality of this monastic site., Le ricerche alla base di questo articolo sono state condotte nel quadro del progetto di ricerca Poder y Represesentaciones en la Edad Moderna, finanziato dal Ministerio de Ciencia e Innovación de España (PID2020-115565GB-C21).
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Epigenome-Wide Comparative Study Reveals Key Differences Between Mixed Connective Tissue Disease and Related Systemic Autoimmune Diseases

  • Carnero Montoro, Elena
  • Barturen, Guillermo
  • Povedano, Elena
  • Kerick, Martin
  • Martinez Bueno, Manuel
  • Ballestar Tarín, Esteban
  • Martin, Javier
  • Teruel, María
  • Alarcon Riquelme, Marta E.
  • PRECISESADS Clinical Consortium
Mixed Connective Tissue Disease (MCTD) is a rare complex systemic autoimmune disease (SAD) characterized by the presence of increased levels of anti-U1 ribonucleoprotein autoantibodies and signs and symptoms that resemble other SADs such as systemic sclerosis (SSc), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE). Due to its low prevalence, this disease has been very poorly studied at the molecular level. We performed for the first time an epigenome-wide association study interrogating DNA methylation data obtained with the Infinium MethylationEPIC array from whole blood samples in 31 patients diagnosed with MCTD and 255 healthy subjects. We observed a pervasive hypomethylation involving 170 genes enriched for immune-related function such as those involved in type I interferon signaling pathways or in negative regulation of viral genome replication. We mostly identified epigenetic signals at genes previously implicated in other SADs, for example MX1, PARP9, DDX60, or IFI44L, for which we also observed that MCTD patients exhibit higher DNA methylation variability compared with controls, suggesting that these sites might be involved in plastic immune responses that are relevant to the disease. Through methylation quantitative trait locus (meQTL) analysis we identified widespread local genetic effects influencing DNA methylation variability at MCTD-associated sites. Interestingly, for IRF7, IFI44 genes, and the HLA region we have evidence that they could be exerting a genetic risk on MCTD mediated through DNA methylation changes. Comparison of MCTD-associated epigenome with patients diagnosed with SLE, or Sjogren's Syndrome, reveals a common interferon-related epigenetic signature, however we find substantial epigenetic differences when compared with patients diagnosed with rheumatoid arthritis and systemic sclerosis. Furthermore, we show that MCTD-associated CpGs are potential epigenetic biomarkers with high diagnostic value. Our study serves to reveal new genes and pathways involved in MCTD, to illustrate the important role of epigenetic modifications in MCTD pathology, in mediating the interaction between different genetic and environmental MCTD risk factors, and as potential biomarkers of SADs.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The potential of PTPN22 as a therapeutic target for rheumatoid arthritis

  • Carmona, Francisco David
  • Martín, J.
PTPN22 encodes a lymphoid-specific tyrosine phosphatase (LYP) that is a master regulator of the immune response. This gene is a major susceptibility factor for a wide range of autoimmune conditions, including rheumatoid arthritis (RA) for which it represents the strongest non-HLA contributor to disease risk. A missense PTPN22 allele (R620W) affecting the protein-protein interaction of LYP with other relevant players was described as the functional variant of the association. This review will focus on the role of PTPN22 in the pathogenic mechanisms underlying RA predisposition and discuss the possibility of developing LYP-based treatment strategies with a potential application in clinical practice. Areas covered: This review covers the literature showing how PTPN22 is implicated in signalling pathways involved in the autoimmune and autoinflammatory processes underlying RA. Insights obtained from studies aimed at developing novel selective LYP suppressors for treating RA are summarized. Expert opinion: Targeting key risk factors during the early steps of the disease may represent a good strategy to accomplish complete disease remission. As cumulating evidences suggest that PTPN22 R620W is a gain-of-function variant, a growing interest in developing LYP inhibitors has arisen. The potential efficacy and possible application of such compounds are discussed., FDC was recipient of a grant from the 'Ramon y Cajal' programme of the Spanish Ministry of Economy and Competitiveness (RYC-2014-16458). JM was founded by Instituto de Salud Carlos III (ISCIII), Spain, through the RETICS Program RD16/0012/0004 (RIER), and the EU/EFPIA Innovative Medicines Initiative Joint Undertaking PRECISESADS (ref: 115565)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies

  • López-Isac, Elena
  • Martin, J. E.
  • Assassi, Shervin
  • Simeón, Carmen P.
  • Carreira, Patricia E.
  • Ortego-Centeno, Norberto
  • Freire, María del Carmen
  • Beltrán, E.
  • Narváez, Javier
  • Alegre-Sancho, Juan-José
  • Fernández-Gutiérrez, Benjamín
  • Balsa, Alejandro
  • Ortiz, Ana María
  • González-Gay, Miguel A.
  • Beretta, Lorenzo
  • Santaniello, Alessandro
  • Bellocchi, Chiara
  • Lunardi, C.
  • Moroncini, Gianluca
  • Gabrielli, Armando
  • Witte, Torsten
  • Hunzelmann, Nicolas
  • Distler, Jörg H. W.
  • Riekemasten, Gabriella
  • van der Helm-Van Mil, Annette H. M.
  • Vries-Bouwstra, Jeska K. de
  • Magro-Checa, Cesar
  • Voskuyl, Alexandre E.
  • Vonk, Madelon C.
  • Molberg, Oyvind
  • Merriman, Tony R.
  • Hesselstrand, Roger
  • Nordin, A.
  • Padyukov, Leonid
  • Herrick, A.
  • Eyre, Steve
  • Koeleman, B. P.
  • Denton, Christopher
  • Fonseca, Carmen
  • Radstake, T. R.
  • Worthington, J.
  • Mayes, Maureen D.
  • Martín, J.
Autoría conjunta: Spanish Scleroderma Grp, Objective. Systemic sclerosis (SSc) and rheumatoid arthritis (RA) are autoimmune diseases that have similar clinical and immunologic characteristics. To date, several shared SSc-RA genetic loci have been identified independently. The aim of the current study was to systematically search for new common SSc-RA loci through an interdisease meta-genome-wide association (meta-GWAS) strategy. Methods. The study was designed as a meta-analysis combining GWAS data sets of patients with SSc and patients with RA, using a strategy that allowed identification of loci with both same-direction and opposite-direction allelic effects. The top single-nucleotide polymorphisms were followed up in independent SSc and RA case-control cohorts. This allowed an increase in the sample size to a total of 8,830 patients with SSc, 16,870 patients with RA, and 43,393 healthy controls. Results. This cross-disease meta-analysis of the GWAS data sets identified several loci with nominal association signals (P<5 x 10(-6)) that also showed evidence of association in the disease-specific GWAS scans. These loci included several genomic regions not previously reported as shared loci, as well as several risk factors that were previously found to be associated with both diseases. Follow-up analyses of the putatively new SSc-RA loci identified IRF4 as a shared risk factor for these 2 diseases (P-combined=3.29 x 10(-12)). Analysis of the biologic relevance of the known SSc-RA shared loci identified the type I interferon and interleukin-12 signaling pathways as the main common etiologic factors. Conclusion. This study identified a novel shared locus, IRF4, for the risk of SSc and RA, and highlighted the usefulness of a cross-disease GWAS meta-analysis strategy in the identification of common risk loci., Supported by a grant from the Ministerio de Educacion, Cultura y Deporte through the program FPU (to Dr. Lopez-Isac), grant 115565 from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking PRECISESADS (ref. no. 115565) and BIO-1395 from the Junta de Andalucia, grant PI-0590-2010 from the Consejeria de Salud y Bienestar Social, Junta de Andalucia, Spain (to Dr. Ortego-Centeno), a VIDI laureate from the Dutch Association of Research and Dutch Arthritis Foundation (to Dr. Radstake), and grant SAF2012-34435 from the Spanish Ministry of Economy and Competitiveness (to Dr. J. Martin). Dr. Assassi's work was supported by grants KL2-RR-024149-04 and K23-AR-061436 from the NIH, grant 3-UL1-RR-024148 from the NIH National Center for Research Resources, and grant U01-1U01AI09090 from the NIH National Institute of Allergy and Infectious Diseases. Dr. Mayes' work was supported by grant P50-AR-054144 from the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Centers of Research Translation, grant N01-AR-0-2251 from the NIAMS SSc Family Registry and DNA Repository, grant PR-1206877 from the Department of Defense, and grant R01-AR-055258 from the NIAMS., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Epigenome-Wide Comparative Study Reveals Key Differences Between Mixed Connective Tissue Disease and Related Systemic Autoimmune Diseases.

  • Carnero-Montoro, Elena
  • Barturen, Guillermo
  • Povedano, Elena
  • Kerick, Martin
  • Martínez-Bueno, Manuel
  • PRECISESADS Clinical Consortium
  • Ballestar, Estéban
  • Martín, J.
  • Teruel, María
  • Alarcón-Riquelme, M. E.
Mixed Connective Tissue Disease (MCTD) is a rare complex systemic autoimmune disease (SAD) characterized by the presence of increased levels of anti-U1 ribonucleoprotein autoantibodies and signs and symptoms that resemble other SADs such as systemic sclerosis (SSc), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE). Due to its low prevalence, this disease has been very poorly studied at the molecular level. We performed for the first time an epigenome-wide association study interrogating DNA methylation data obtained with the Infinium MethylationEPIC array from whole blood samples in 31 patients diagnosed with MCTD and 255 healthy subjects. We observed a pervasive hypomethylation involving 170 genes enriched for immune-related function such as those involved in type I interferon signaling pathways or in negative regulation of viral genome replication. We mostly identified epigenetic signals at genes previously implicated in other SADs, for example MX1, PARP9, DDX60, or IFI44L, for which we also observed that MCTD patients exhibit higher DNA methylation variability compared with controls, suggesting that these sites might be involved in plastic immune responses that are relevant to the disease. Through methylation quantitative trait locus (meQTL) analysis we identified widespread local genetic effects influencing DNA methylation variability at MCTD-associated sites. Interestingly, for IRF7, IFI44 genes, and the HLA region we have evidence that they could be exerting a genetic risk on MCTD mediated through DNA methylation changes. Comparison of MCTD-associated epigenome with patients diagnosed with SLE, or Sjögren's Syndrome, reveals a common interferon-related epigenetic signature, however we find substantial epigenetic differences when compared with patients diagnosed with rheumatoid arthritis and systemic sclerosis. Furthermore, we show that MCTD-associated CpGs are potential epigenetic biomarkers with high diagnostic value. Our study serves to reveal new genes and pathways involved in MCTD, to illustrate the important role of epigenetic modifications in MCTD pathology, in mediating the interaction between different genetic and environmental MCTD risk factors, and as potential biomarkers of SADs., This study received support from the Innovative Medicines Initiative Joint Undertaking under the grant agreement no.115565, resources of which are composed of the financial contribution of the European Union’s Seventh Framework Program (FP7/2007-2013) and the EFPIA companies’ in kind contribution and the in-cash contribution of Sanofi/Genzyme to Alarcón-Riquelme’s lab. EC-M was funded by the Post-doctoral Training Subprogramme Juan de la Cierva-Ministry of Economy and Competitiveness (FJCI_2014_20652).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants

  • Castellini-Pérez, Olivia
  • Povedano, Elena
  • Barturen, Guillermo
  • Martínez-Bueno, Manuel
  • Kerick, Martin
  • Marañón, Concepción
  • Martín, Javier
  • Ballestar, Estéban
  • Orietta Borghi, Maria
  • PRECISESADS Clinical Consortium
  • PRECISESADS Flow Cytometry Consortium
  • Carnero-Montoro, Elena
  • Alarcón-Riquelme, M. E.
PRECISEADS Clinical Consortium and PRECISEADS Flow Cytometry Study Group: et al., The heterogeneity of systemic lupus erythematosus (SLE) can be explained by epigenetic alterations that disrupt transcriptional programs mediating environmental and genetic risk. This study evaluated the epigenetic contribution to SLE heterogeneity considering molecular and serological subtypes, genetics and transcriptional status, followed by drug target discovery. We performed a stratified epigenome-wide association studies of whole blood DNA methylation from 213 SLE patients and 221 controls. Methylation quantitative trait loci analyses, cytokine and transcription factor activity - epigenetic associations and methylation-expression correlations were conducted. New drug targets were searched for based on differentially methylated genes. In a stratified approach, a total of 974 differential methylation CpG sites with dependency on molecular subtypes and autoantibody profiles were found. Mediation analyses suggested that SLE-associated SNPs in the HLA region exert their risk through DNA methylation changes. Novel genetic variants regulating DNAm in disease or in specific molecular contexts were identified. The epigenetic landscapes showed strong association with transcription factor activity and cytokine levels, conditioned by the molecular context. Epigenetic signals were enriched in known and novel drug targets for SLE. This study reveals possible genetic drivers and consequences of epigenetic variability on SLE heterogeneity and disentangles the DNAm mediation role on SLE genetic risk and novel disease-specific meQTLs. Finally, novel targets for drug development were discovered., Open access funding provided by Karolinska Institute., E.C.M and O.C.P have been funded by Grants for the financing of Research, Development, and Innovation (R + D + I) in Biomedicine and Health Sciences in Andalusia for the year 2021, project co-financed by 80% by funds of the FEDER Operational Program of Andalusia 2014-2020 (File Number: PECOVID-0072-2020). Funding for this work has been provided by the Plan Estatal, Ministerio de Ciencia e Innovación a MEAR No. PID2020-113776GB-I00, as well as to the Lupus Research Alliance/BMS Award to M.E.A.R. and the Diversity Supplement to O.C.P. Funding for the preparation of this manuscript has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no 115565, resources composed of the financial contribution from the European Union’s Seventh Framework Program (FP7/2007-2013) and the EFPIA companies’ in kind contribution and from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 831434 (3TR). The JU receives support from the European Union’s Horizon 2020 research and innovation program and EFPIA. The contributions of the consortia to this study are gratefully acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Sensorial and Sonic Aspects in the Writings of the "English-American" Thomas Gage (c. 1603-1656) on Mexico and Guatemala

  • Irving, David Ronald Marshall
Objective/Context: This article examines dimensions of sensoriality within the writings of Thomas Gage (c. 1603-1656) regarding his experiences as a Dominican friar in Mexico and Guatemala between 1625 and 1637. His 1648 travelogue, The English-American His Travail by Sea and Land, is the first detailed eyewitness report of daily life in the Spanish colonies by an English writer. Yet this work and his other writings were published after he converted to Protestantism and formed an explicit part of the anti-Catholic discourse in England. Methodology: Written from a historical-musicological perspective, this study is informed by the approaches of sensory history to identify and critique the sonic episodes and metaphors in Gage's texts. It critically analyzes his travelogue and investigates how his accounts of musical, gastronomic, and religious experiences underpinned and influenced his political and theological views. To draw out his unique perspectives on music, it also considers soundscapes and the material and cultural dimensions in his descriptions. Originality: Recent scholarship has shown how Gage's transnational and transconfessional identities did not fit traditional frameworks of analysis and limited scholarly attention to him. Lately, however, researchers have highlighted his mention of the senses. This article focuses specifically on hearing to show that his writings contain unique viewpoints and data on music and sound. Conclusions: Assessment of Thomas Gage within the frameworks of musicology and sensory history demonstrates that he invoked the senses in seemingly unique ways, especially by conflating their physical and metaphysical dimensions when critiquing Catholic practices in colonial contexts., Research for this article has been carried out within the framework of the project “Poder y Representaciones Culturales en la Época Moderna,” financed by the Agencia Estatal de Investigación, Government of Spain (PID2020-115565GB-C21). I am grateful to my colleagues on this project for their support of the present study. I would also like to thank Javier Marín López, Ireri E. Chávez Bárcenas, and the two anonymous peer reviewers for their helpful and constructive feedback on my manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Iberian Sources for the Historiography of Musics in the Early Modern Moluccas (Maluku)

  • Irving, David Ronald Marshall
This chapter examines Iberian sources (Portuguese and Spanish) from the 16th–17th centuries to reconstruct musical practices in the early modern Moluccas (Maluku, Indonesia). It analyzes three key textual categories: (1) António Galvão’s 1544 treatise detailing indigenous instruments (e.g., gongs, tifa drums), court rituals, and dances like lego-lego; (2) Jesuit missionary letters documenting musical evangelization, including localized Catholic chants, polyphony, and conflicts over indigenous performances; and (3) Bartolomé Leonardo de Argensola’s 1609 Conquista de las Islas Malucas, which synthesizes intercultural sonic encounters. The author highlights how these sources reveal musical hybridity, power dynamics in colonial encounters, and gaps in historiography, emphasizing music’s role in diplomacy, religion, and cultural identity amid Iberian-Dutch rivalries.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Iberian Sources for the Historiography of Musics in the Early Modern Moluccas (Maluku)

  • Irving, David Ronald Marshall
This chapter examines Iberian sources (Portuguese and Spanish) from the 16th–17th centuries to reconstruct musical practices in the early modern Moluccas (Maluku, Indonesia). It analyzes three key textual categories: (1) António Galvão’s 1544 treatise detailing indigenous instruments (e.g., gongs, tifa drums), court rituals, and dances like lego-lego; (2) Jesuit missionary letters documenting musical evangelization, including localized Catholic chants, polyphony, and conflicts over indigenous performances; and (3) Bartolomé Leonardo de Argensola’s 1609 Conquista de las Islas Malucas, which synthesizes intercultural sonic encounters. The author highlights how these sources reveal musical hybridity, power dynamics in colonial encounters, and gaps in historiography, emphasizing music’s role in diplomacy, religion, and cultural identity amid Iberian-Dutch rivalries.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Global Soundscapes from the First Voyage of Circumnavigation, 1519-1522

  • Irving, David Ronald Marshall
Examination of the global soundscapes documented during the Magellan-Elcano circumnavigation (1519–1522), primarily through Antonio Pigafetta’s eyewitness account. It explores how sounds—ranging from natural phenomena and Indigenous musical performances to artillery discharges and liturgical chants—shaped cross-cultural encounters and colonial power dynamics. The analysis highlights the role of sonic intimidation (e.g., cannons), trade items like hawksbells, and musical exchanges in Southeast Asia. Irving critiques Eurocentric narratives, emphasizing silenced Indigenous perspectives while advocating for "global music history" frameworks. The study underscores sound’s centrality in mapping early modern intercultural contact, colonial aggression, and sensory historiography., Análisis de los paisajes sonoros globales del primer viaje de circunnavegación (1519–1522), basándose en el relato de Antonio Pigafetta. Examina sonidos como instrumentos indígenas (gongs filipinos, maracas), salvas de artillería usadas para intimidar, campanas de trueque y rezos litúrgicos que marcaron encuentros culturales. Destaca cómo los sonidos reflejaron desequilibrios de poder colonial, especialmente en Filipinas y las Molucas, donde la música local contrastó con la imposición sonora europea. Irving cuestiona narrativas eurocéntricas, recuperando voces silenciadas (como el esclavo Enrique) y propone una "historia musical global" para reinterpretar estos registros históricos sensoriales., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Discovery of core genes for systemic lupus erythematosus via genome-wide aggregated trans-effects analysis

  • Iakovliev, Andrii
  • Castellini-Pérez, Olivia
  • Erabadda, Buddhiprabha
  • Martín, Javier
  • Barturen, Guillermo
  • McKeigue, Paul M.
  • Carnero-Montoro, Elena
  • Alarcón-Riquelme, M. E.
  • Spiliopoulou, Athina
The "omnigenic" hypothesis postulates that the polygenic effects of common variants on a typical complex trait coalesce on relatively few core genes through trans-effects on their expression. Our aim was to identify core genes for systemic lupus erythematosus (SLE) by testing for association with genome-wide aggregated trans-effects (GATE) scores for gene expression in a large genetic dataset (5267/4909 SLE cases/controls). SLE was strongly associated with upregulation of expression of eight interferon-stimulated genes driven by shared trans-effects. We estimate that trans-effects on interferon signaling account for 9% of the total genetic effect on SLE risk. Outside this pathway, GATE analysis detected twenty putative core genes for SLE. Direct protein measurements for these genes were strongly associated with SLE in UK Biobank. Two putative core genes (TNFRSF17, TNFRSF13B) encode receptors (BCMA, TACI) expressed on B cells; their ligands (BAFF, APRIL) are targeted by drugs licensed or in development for SLE. Four genes (PDCD1, LAG3, TNFRSF9, CD27) encode receptors that have been characterized as immune checkpoints, and three (CD5L, SIGLEC1, CXCL13) are biomarkers of SLE disease activity. These results provide genetic support for existing drug targets in SLE (interferon signaling, BAFF/APRIL signaling) and identify other possible therapeutic targets including immune checkpoint receptors., The authors express their gratitude to all study participants, and medical and administrative staff who helped with participant recruitment, and sample and data collection, and were thus an integral part to the delivery of this study. This research has been conducted using the UK Biobank Resource under application number 23652. The authors thank Yanick Crow for his valuable insights in interpreting results for the type I interferon signaling pathway and its role in SLE. Data from this work has been previously presented at the annual conference of the European Society of Human Genetics (ESHG 2024) held in Berlin, Germany. The development of the GENOSCORES platform was supported by a Springboard Award (SBF006/1109) from the Academy of Medical Sciences, supported in turn by the Wellcome Trust, the UK Government Department of Business, Energy and Industrial Strategy, the British Heart Foundation, and Diabetes UK. AI was supported by the Medical Research Council Cross Disciplinary Fellowship (XDF) Programme (MC_FE_00035). EC-M is funded by EMERGIA grant 30BM280101 by Consejería de Universidad, Investigación e Innovación, Junta Andalucía, Spain. The PRECISESADS study was supported by the EU/EFPIA Innovative Medicines Initiative Joint Undertaking (PRECISESADS, grant n. 115565), including in-kind contributions from the EFPIA members involved., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Novel pleiotropic loci link vascular and immune pathways in systemic sclerosis and primary Raynaud's phenomenon

  • Rangel-Peláez, Carlos
  • Rodríguez-Martín, Inmaculada
  • Rosa Baez, Carlos de la
  • Kerick, Martin
  • Guillén del Castillo, Alfredo
  • Simeón, Carmen P.
  • Callejas-Rubio, José Luis
  • Distler, Oliver
  • Proudman, Susanna
  • Nikpour, Mandana
  • Hunzelmann, Nicolas
  • Moroncini, Gianluca
  • Vries-Bouwstra, Jeska K. de
  • Herrick, A.
  • Allanore, Yannick
  • Alarcón-Riquelme, M. E.
  • Beretta, Lorenzo
  • Mayes, Maureen D.
  • Denton, Christopher
  • Assassi, Shervin
  • Martín, Javier
  • Acosta-Herrera, Marialbert
  • Ortiz-Fernández, Lourdes
  • International SSc Group
  • PRECISESADS Clinical Consortium
  • Australian Scleroderma Interest Group (ASIG)
[Objective] Raynaud’s phenomenon (RP) is the first noticeable symptom of systemic sclerosis (SSc), appearing even years before other signs. Vascular and immune pathways, hallmarks in SSc pathogenesis, are implicated in primary RP. Hence, we aimed to define the shared genetic architecture between these conditions to explore pathogenic mechanisms and whether pleiotropic loci could help identify primary RP patients at increased genetic risk of developing SSc., [Methods] We analysed genome-wide association study (GWAS) summary statistics for primary RP (4 986 cases and 850 981 controls) and SSc (10 654 cases and 18 043 controls). We performed a cross-trait meta-analysis (∼8.6M single nucleotide polymorphisms) to identify variants associated with both diseases. Functional annotation was used to prioritise potential causal genes. We also constructed a polygenic risk score (PRS) to assess clinical implications., [Results] Beyond the well-known HLA associations, we identified five additional pleiotropic loci, including MEOX2 as a novel association for both traits with opposing effects, ADRA2A representing a novel genetic factor for SSc, and IL12A, NFKB1 and TNIP1 as novel loci for primary RP. Functional annotation highlighted vascular and inflammatory pathways. Finally, the PRS model shows modest discrimination (area under the curve = 0.57). However, it allows the identification of primary RP individuals at high genetic risk of developing SSc (75th percentile, relative risk =1.29 [95% CI 1.02, 1.62]; P-value= 3.58 × 10−2)., [Conclusion] This study reveals a genetic link between primary RP and SSc, identifying five novel pleiotropic loci and supporting the potential of genetic profiling for early risk assessment and personalised monitoring strategies., This work was supported by Cooperative Research Networks Oriented to Health Results (RICORS), Inflammatory Diseases Network (REI) (RD21/0002/0039; RD24/0007/0016) from Carlos III Health Institute (ISCIII); grant PID2022-139292OB-I00 funded by MICIU/AEI/10.13039/501100011033 and by FSE+; and by the Innovative Medicines Initiative Joint Undertaking (grant 115565; PRECISESADS project), resources of which are composed of financial contribution from the European Union’s Seventh Framework Program (FP7/2007–2013) and European Federation of Pharmaceutical Industries and Associations companies’ in-kind contribution. This research was also supported by the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (NIHR203308). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. L.O.-F. is recipient of a Ramon y Cajal fellowship [RYC2022-036635-I] funded by MICIU/AEI/10.13039/501100011033 and by ESF+. C.R.-B. was supported by the program FPU: [FPU22/01652], funded by the Spanish Ministry of Science Innovation and Universities. I.R.-M. was supported by the program FPU: [FPU21/02746], funded by the Spanish Ministry of University. C.R.-P. was funded by Grant PREP2022-000747 funded by MICIU/AEI/10.13039/501100011033 and by ESF+., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Sex-specific autosomal susceptibility loci in systemic sclerosis: a genome-wide association study

  • Rodríguez-Martín, Inmaculada
  • Kerick, Martin
  • Rangel-Peláez, Carlos
  • Rosa-Baez, Carlos
  • Borrego Yaniz, Gonzalo
  • Ortiz-Fernández, Lourdes
  • Guillén del Castillo, Alfredo
  • Simeón-Aznar, Carmen P.
  • Callejas-Rubio, José Luis
  • Distler, Oliver
  • Proudman, Susanna
  • Nikpour, Mandana
  • Hunzelmann, Nicolas
  • Vries-Bouwstra, Jeska K. de
  • Herrick, A.
  • Allanore, Yannick
  • Alarcón-Riquelme, M. E.
  • Beretta, Lorenzo
  • Assassi, Shervin
  • Denton, Christopher
  • Mayes, Maureen D.
  • Martín, Javier
  • Acosta-Herrera, Marialbert
  • International SSc Group
  • PRECISESADS Clinical Consortium
  • Australian Scleroderma Interest Group (ASIG)
International SSc Group: P. Carreira, I. Castellvi, R. Ríos, N. Ortego-Centeno, R. García Portales, A. Fernández-Nebro, F.J. García-Hernández, M.A. Aguirre, B. Fernández-Gutiérrez, L. Rodríguez-Rodríguez, P. García de la Peña, E. Vicente, J.L. Andreu, M. Fernández de Castro, F.J. López-Longo, V. Fonollosa, A. Guillén, G. Espinosa, C. Tolosa, A. Pros, E. Beltrán, M. Rodríguez Carballeira, F.J. Narváez, M. Rubio Rivas, V. Ortiz-Santamaría, A.B. Madroñero, M.A. González-Gay, B. Díaz, L. Trapiella, M.V. Egurbide, P. Fanlo-Mateo, L. Saez-Comet, F. Díaz, J.A. Roman-Ivorra, J.J. Alegre Sancho, M. Freire, F.J. Blanco Garcia, N. Oreiro, T. Witte, A. Kreuter, G. Riemekasten, P. Airo, C. Magro, A.E. Voskuyl, M.C. Vonk, R. Hesselstrand, A. Nordin, C. Lunardi, G. Moroncini, A. Gabrielli, A. Hoffmann-Vold, J.H.W. Distler, L. Padyukov, B.P.C. Koeleman, T.R.D.J. Radstake, G. Orozco, A. Barton, C. Fonseca, The PRECISESADS Clinical Consortium: Barbara Vigone, Jacques-Olivier Pers, Alain Saraux, Valérie Devauchelle-Pensec, Divi Cornec, Sandrine Jousse-Joulin, Bernard Lauwerys, Julie Ducreux, Anne-Lise Maudoux, Carlos Vasconcelos, Ana Tavares, Esmeralda Neves, Raquel Faria, Mariana Brandão, Ana Campar, António Marinho, Fátima Farinha, Miguel Angel Gonzalez-Gay Mantecón, Ricardo Blanco Alonso, Alfonso Corrales Martínez, Ricard Cervera, Ignasi Rodríguez-Pintó, Gerard Espinosa, Rik Lories, Ellen De Langhe, Nicolas Hunzelmann, Doreen Belz, Torsten Witte, Niklas Baerlecken, Georg Stummvoll, Michael Zauner, Michaela Lehner, Eduardo Collantes, Rafaela Ortega-Castro, M Angeles Aguirre-Zamorano, Alejandro Escudero-Contreras, M Carmen Castro-Villegas, Norberto Ortego, María Concepción Fernández Roldán, Enrique Raya, Inmaculada Jiménez Moleón, Enrique de Ramon, Isabel Díaz Quintero, Pier Luigi Meroni, Maria Gerosa, Tommaso Schioppo, Carolina Artusi, Carlo Chizzolini, Aleksandra Zuber, Donatienne Wynar, Laszló Kovács, Attila Balog, Magdolna Deák, Márta Bocskai, Sonja Dulic, Gabriella Kádár, Falk Hiepe, Velia Gerl, Silvia Thiel, Manuel Rodriguez Maresca, Antonio López-Berrio, Rocío Aguilar-Quesada, Héctor Navarro-Linares, Australian Scleroderma Interest Group: A. Apostolopoulos, N. Ferdowsi, D. Hansen, L.V. Host, G. Major, G.-S. Ngian, A. Quinlivan, L. Ross, J. Sahhar, W. Stevens, M. Tabesh, J. Walker, [Background] Systemic sclerosis is an immune-mediated inflammatory disease with marked sex differences in prevalence and severity. Although genome-wide association studies (GWAS) have advanced the understanding of systemic sclerosis genetics, sex-aware approaches remain scarce. We aimed to address this gap by examining autosomal sex-specific genetic factors in systemic sclerosis., [Methods] Based on a chromosomal definition of sex, we conducted a sex-stratified autosomal meta-analysis of GWAS in systemic sclerosis. We retrieved patient-level and control data from a previous GWAS for systemic sclerosis and newly recruited participants from an international multicentre collaboration (data cutoff June 1, 2024). Adult patients (aged ≥18 years) were required to meet the 2013 American College of Rheumatology–European League Against Rheumatism classification criteria or the criteria for early systemic sclerosis proposed by LeRoy and Medsger, 2001. Patients with systemic sclerosis were compared with healthy controls through sex-stratified analyses. Sex-specific loci were functionally annotated and a sex-differential expression analysis was performed to validate the findings. Additionally, we performed a drug repurposing analysis to explore the clinical implications of our findings. People with lived experience of systemic sclerosis were not involved in the study design or conduct., [Findings] After quality control filtering, we included 10 653 patients with systemic sclerosis (1556 male and 9097 female) and 18 043 controls (6990 male and 11 053 female). We identified eight sex-specific loci associated with systemic sclerosis: one novel male-specific locus (BCL11A odds ratio [OR] 1·32 [95% CI 1·20–1·45], p=8·39 × 10–9), two novel female-specific loci (IRF4 OR 0·78 [0·71–0·85], p=2·36 × 10–8 RPL3-PDGFB OR 1·19 [1·12–1·26], p=3·18 × 10–8), and five previously known loci now characterised as female-specific. Functional analyses implicated 39 candidate genes, of which five (IL12RB2, ARHGAP31, UBL7, CSK, and MPI) showed sex-differential expression in patients with systemic sclerosis. Two approved drugs, fostamatinib and dasatinib, were identified as potential repurposing candidates for systemic sclerosis sex-aware treatment., [Interpretation] We report the first evidence of sex-specific genetic architecture in systemic sclerosis. These findings offer insight into the molecular basis of sex differences in the disease, highlighting both IL12RB2 gene and interferon signalling. These results also support the development of sex-aware precision medicine approaches., This work was supported by the Instituto de Salud Carlos III (CP21/00132, PI22/00092 [co-financed by the EU], and Redes de Investigación Cooperativa Orientadas a Resultados en Salud [RD21/0002/0039 and RD24/0007/0016]) and the Innovative Medicines Initiative Joint Undertaking (grant 115565; PRECISESADS project; these resources comprise financial contribution from the EU's Seventh Framework Program [FP7/2007–2013] and European Federation of Pharmaceutical Industries and Associations companies' in-kind contribution). IR-M (FPU21/02746) and CR-B (FPU22/01652) were supported by the programme Formación de Profesorado Universitario funded by the Spanish Ministry of Science, Innovation, and Universities (MICIU). CR-P was supported by grant PREP2022-000747 funded by MICIU/AEI/10.13039/501100011033 and by the European Social Fund Plus (ESF+). GB-Y's contract is part of the grant PREP2022-000712 funded by MICIU/AEI/10.13039/501100011033 and by ESF+. LO-F is a recipient of a Ramon y Cajal fellowship (RYC2022-036635-I) funded by MICIU/AEI/10.13039/501100011033 and by ESF+. The research was also supported by the UK National Institute for Health and Care Research (NIHR)Manchester Clinical Research Facility (NIHR203956). The views expressed are our own and not necessarily those of the NIHR or the UK Department of Health and Social Care. We thank Sofia Vargas and Gema Robledo for their exceptional technical expertise. We also thank all of the participants who provided the data for their essential collaboration and all members of the PRECISESADS consortium. During the preparation of this work we used ChatGPT (GPT 4) to enhance the writing of some sections of the manuscript. After using this tool, we reviewed and edited the content as needed and take full responsibility for the content of the published article. This research is part of the doctoral degree awarded to IR-M within the Biomedicine programme from the University of Granada., Instituto de Salud Carlos III, EU's Seventh Framework Program, and European Federation of Pharmaceutical Industries and Associations companies., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Epigenome-Wide Comparative Study Reveals Key Differences Between Mixed Connective Tissue Disease and Related Systemic Autoimmune Diseases

  • Carnero Montoro, Elena
  • Barturen, Guillermo
  • Povedano, Elena
  • Kerick, Martin
  • Martinez Bueno, Manuel
  • Ballestar Tarín, Esteban
  • Martin, Javier
  • Teruel, María
  • Alarcon Riquelme, Marta E.
  • PRECISESADS Clinical Consortium
Mixed Connective Tissue Disease (MCTD) is a rare complex systemic autoimmune disease (SAD) characterized by the presence of increased levels of anti-U1 ribonucleoprotein autoantibodies and signs and symptoms that resemble other SADs such as systemic sclerosis (SSc), rheumatoid arthritis (RA), and systemic lupus erythematosus (SLE). Due to its low prevalence, this disease has been very poorly studied at the molecular level. We performed for the first time an epigenome-wide association study interrogating DNA methylation data obtained with the Infinium MethylationEPIC array from whole blood samples in 31 patients diagnosed with MCTD and 255 healthy subjects. We observed a pervasive hypomethylation involving 170 genes enriched for immune-related function such as those involved in type I interferon signaling pathways or in negative regulation of viral genome replication. We mostly identified epigenetic signals at genes previously implicated in other SADs, for example MX1, PARP9, DDX60, or IFI44L, for which we also observed that MCTD patients exhibit higher DNA methylation variability compared with controls, suggesting that these sites might be involved in plastic immune responses that are relevant to the disease. Through methylation quantitative trait locus (meQTL) analysis we identified widespread local genetic effects influencing DNA methylation variability at MCTD-associated sites. Interestingly, for IRF7, IFI44 genes, and the HLA region we have evidence that they could be exerting a genetic risk on MCTD mediated through DNA methylation changes. Comparison of MCTD-associated epigenome with patients diagnosed with SLE, or Sjogren's Syndrome, reveals a common interferon-related epigenetic signature, however we find substantial epigenetic differences when compared with patients diagnosed with rheumatoid arthritis and systemic sclerosis. Furthermore, we show that MCTD-associated CpGs are potential epigenetic biomarkers with high diagnostic value. Our study serves to reveal new genes and pathways involved in MCTD, to illustrate the important role of epigenetic modifications in MCTD pathology, in mediating the interaction between different genetic and environmental MCTD risk factors, and as potential biomarkers of SADs.
Recercat. Dipósit de la Recerca de Catalunya
Publication Capítulo o parte de un libro (BookPart)

I viceré conti di Miranda e la circolazione di reliquie nella Spagna tra Cinque e Seicento, Viceroy counts of Miranda and the circulation of relics in Spain between the sixteenth and seventeenth centuries

  • Viceconte, Milena
Il presente lavoro si propone di affrontare il fenomeno della circolazione di reliquie tra l’Italia e la Spagna durante prima età moderna, attraverso l’analisi delle raccolte dei VI conti di Miranda e delle loro donazioni alle fondazioni religiose spagnole. Come attestano varie fonti d’archivio, i conti María e Juan de Zúñiga y Avellaneda (costui viceré di Napoli tra il 1586 e il 1595) effettuarono durante il soggiorno a Napoli varie acquisizioni di reliquie e opere d’arte a soggetto sacro, che furono oggetto in momenti diversi di donazioni ai luoghi religiosi legati al patronato familiare, come la chiesa di Nuestra Señora de la Vid, che dal 1420 ospitava il pantheon dei Zúñiga y Avellaneda. Di particolare interesse è la donazione alle monache agostiniane del monastero di patronato reale dell'Encarnación di Madrid nel 1630 da parte della contessa di Miranda per disposizione testamentaria, in quanto portò al trasferimento di un corpus significativo di resti sacri, tra cui un’ampolla con il sangue del martire Pantaleone de Nicomedia. Attorno a tale reliquia, che una volta l’anno è oggetto del singolare fenomeno della liquefazione, si generò sin da subito una speciale venerazione, destinata a divenire un tratto distintivo della spiritualità di questo complesso monastico., The present paper aims to examine the phenomenon of the circulation of relics between Italy and Spain during the early modern period, through the analysis of the collections of the VI counts of Miranda and their donations to Spanish religious foundations. As documented by several archive records, the counts María and Juan de Zúñiga y Avellaneda (the latter viceroy of Naples between 1586 and 1595) made a number of acquisitions of relics and religious works of art during their stay in Naples, which were donated at different moments to the religious institutions linked to their family patronage, such as the church of Nuestra Señora de la Vid, which had housed the pantheon of the Zúñiga y Avellaneda family since 1420. The donation to the Augustinian nuns of the Royal Patronage Monastery of the Encarnación in Madrid in 1630, ordered by the Countess of Miranda by testamentary disposition, was especially interesting, as it allowed the transfer of a significant corpus of sacred remains, including an ampoule with the blood of the martyr Pantaleon of Nicomedia. Around this relic, which once a year is subject to the singular phenomenon of liquefaction, a special veneration was immediately generated, which was soon become a distinctive feature of the spirituality of this monastic site., Le ricerche alla base di questo articolo sono state condotte nel quadro del progetto di ricerca Poder y Represesentaciones en la Edad Moderna, finanziato dal Ministerio de Ciencia e Innovación de España (PID2020-115565GB-C21).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

  • Kerick, Martin|||0000-0002-6298-4514
  • Acosta-Herrera, Marialbert|||0000-0002-9868-6535
  • Simeón-Aznar, Carmen Pilar|||0000-0003-3390-9029
  • Callejas Rubio, Jose Luis|||0000-0002-1653-0087
  • Assassi, Shervin|||0000-0002-8059-9978
  • Carreira, Patricia E.|||0000-0001-8279-3806
  • Castellvi, Ivan|||0000-0002-5410-5807
  • Ríos, Raquel
  • García-Portales, Rosa
  • Fernández-Nebro, Antonio|||0000-0002-2962-9844
  • García-Hernández, Francisco Jose|||0000-0002-2600-0485
  • Aguirre, Mª Angeles|||0000-0002-5653-4293
  • Fernández-Gutiérrez, Benjamín
  • Rodriguez-Rodriguez, Luis|||0000-0002-2869-7861
  • García de la Peña-Lefebvre, Paloma
  • Vicente-Rabaneda, Esther Francisca
  • Andréu, José Luis|||0000-0002-6002-1239
  • Fernández de Castro, Mónica
  • López Longo, Francisco Javier
  • Fonollosa Pla, Vicent
  • Guillén-Del-Castillo, Alfredo|||0000-0003-0626-507X
  • Espinosa, Gerard|||0000-0003-1336-0163
  • Tolosa, Carlos
  • Pros, Ana|||0000-0003-0266-0531
  • Beltran Catalan, Emma|||0000-0001-8070-6916
  • Rodríguez-Carballeira, Mónica|||0000-0002-8802-0238
  • Narváez, Javier|||0000-0002-1614-8064
  • Rubio Rivas, Manuel|||0000-0002-9548-1374
  • Ortiz-Santamaría, Vera
  • Madroñero, Ana Belén
  • Gonzalez-Gay, MA.|||0000-0002-7924-7406
  • Díaz, Bernardino
  • Trapiella, Luis
  • Egurbide, María Victoria
  • Fanlo-Mateo, Patricia
  • Sáez-Comet, Luis|||0000-0002-9868-6498
  • Díaz, F.
  • Román-Ivorra, José Andrés
  • Alegre-Sancho, Juan José|||0000-0003-1641-0875
  • Freire, Mercedes
  • Garcia, Francisco J.B.
  • Oreiro, Natividad
  • Witte, Torsten
  • Kreuter, Alexander|||0000-0003-2275-499X
  • Riemekasten, Gabriela
  • Airò, Paolo
  • Magro-Checa, César
  • Voskuyl, A.E.|||0000-0002-9699-1827
  • Vonk, Madelon C.
  • Hesselstrand, Roger
  • Nordin, Annika|||0000-0003-1976-4679
  • Lunardi, Claudio|||0000-0001-6446-2990
  • Gabrielli, Armando
  • Hoffmann-Vold, A.
  • Distler, J.H.W.
  • Padyukov, Leonid|||0000-0003-2950-5670
  • Koeleman, B.P.C.
  • Proudman, Susanna M.
  • Nikpour, Mandana
  • Stevens, W.
  • Zochling, Jane M.
  • Sahhar, Joanne|||0000-0003-4220-2906
  • Roddy, J.
  • Nash, P.
  • Tymms, Kathleen
  • Rischmueller, Maureen
  • Lester, Susan Elizabeth
  • Vigone, Barbara
  • Pers, Jacques-Olivier|||0000-0001-7287-5541
  • Saraux, Alain
  • Devauchelle-Pensec, Valérie
  • Cornec, Divi|||0000-0002-9159-702X
  • Jousse-Joulin, Sandrine
  • Lauwerys, Bernard
  • Ducreux, Julie
  • Maudoux, Anne-Lise
  • Vasconcelos, Carlos
  • Tavares, Ana
  • Neves, Esmeralda
  • Faria, Raquel
  • Brandão, Mariana
  • Campar, Ana
  • Marinho, António
  • Farinha, Fátima
  • Almeida, Isabel
  • Blanco, Ricardo|||0000-0003-2344-2285
  • Corrales Martínez, Alfonso
  • Cervera, Ricard
  • Rodríguez-Pintó, Ignasi
  • Lories, Rik
  • De Langhe, Ellen|||0000-0002-4045-2146
  • Belz, Doreen
  • Baerlecken, Niklas
  • Stummvoll, Georg
  • Zauner, Michael
  • Lehner, Michaela
  • Collantes Estevéz, Eduardo|||0000-0002-7647-6289
  • Ortega Castro, Rafaela|||0000-0002-7552-3469
  • Escudero Contreras, Alejandro|||0000-0001-5891-5527
  • Castro-Villegas, Ma Carmen
  • Fernández Roldán, María Concepción
  • Ortego-Centeno, Norberto|||0000-0003-2325-0937
  • Raya, Enrique
  • Jiménez Moleón, Inmaculada
  • de Ramon, Enrique
  • Díaz Quintero, Isabel
  • Meroni, Pier Luigi|||0000-0002-3394-1451
  • Gerosa, Maria|||0000-0001-5241-5847
  • Schioppo, Tommaso|||0000-0001-8359-5131
  • Artusi, Carolina
  • Chizzolini, Carlo
  • Zuber, Aleksandra
  • Wynar, Donatienne
  • Kovács, Laszló
  • Balog, Attila
  • Deák, Magdolna
  • Bocskai, Márta
  • Dulic, Sonja
  • Kádár, Gabriella
  • Hiepe, Falk|||0000-0003-3584-5292
  • Gerl, Velia
  • Thiel, Silvia
  • rodriguez Maresca, Manuel
  • López-Berrio, Antonio
  • Aguilar-Quesada, Rocío|||0000-0003-3125-6634
  • Navarro-Linares, Héctor
  • Hunzelmann, Nicolas
  • Moroncini, Gianluca|||0000-0002-0380-0105
  • de Vries-Bouwstra, Jeska K.
  • Orozco, Gisela|||0000-0002-3479-0448
  • Barton, Anne|||0000-0003-3316-2527
  • Herrick, Ariane|||0000-0003-4941-7926
  • Terao, Chikashi|||0000-0002-6452-4095
  • Allanore, Yannick|||0000-0002-6149-0002
  • Fonseca, Carmen
  • Alarcón-Riquelme, Marta E.|||0000-0002-7632-4154
  • Radstake, Timothy R.D.J.
  • Beretta, Lorenzo|||0000-0002-6529-6258
  • Denton, Christopher P.
  • Mayes, Maureen D.|||0000-0001-5070-2535
  • Martín, Javier|||0000-0002-2202-0622
Copy number (CN) polymorphisms of complement C4 play distinct roles in many conditions, including immune-mediated diseases. We investigated the association of C4 CN with systemic sclerosis (SSc) risk. Imputed total C4, C4A, C4B, and HERV-K CN were analyzed in 26,633 individuals and validated in an independent cohort. Our results showed that higher C4 CN confers protection to SSc, and deviations from CN parity of C4A and C4B augmented risk. The protection contributed per copy of C4A and C4B differed by sex. Stronger protection was afforded by C4A in men and by C4B in women. C4 CN correlated well with its gene expression and serum protein levels, and less C4 was detected for both in SSc patients. Conditioned analysis suggests that C4 genetics strongly contributes to the SSc association within the major histocompatibility complex locus and highlights classical alleles and amino acid variants of HLA-DRB1 and HLA-DPB1 as C4-independent signals.